Literature DB >> 15155480

Pfizer pleads guilty, but drug sales continue to soar.

Jeanne Lenzer.   

Abstract

Keywords:  Health Care and Public Health; Legal Approach; Pfizer Ltd.

Mesh：

Substances：

Year:  2004        PMID： 15155480      PMCID： PMC416587          DOI： 10.1136/bmj.328.7450.1217

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  "Good Publication Practice for Pharmaceutical Companies": where are we now?

Authors:  Elizabeth Wager
Journal:  MedGenMed       Date:  2005-04-18

Review 2.  Topiramate in non-approved indications and acute myopia or angle closure glaucoma.

Authors:  Gloria Cereza; Consuelo Pedrós; Núria Garcia; Joan-Ramon Laporte
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

3.  The imperative to share clinical study reports: recommendations from the Tamiflu experience.

Authors:  Peter Doshi; Tom Jefferson; Chris Del Mar
Journal:  PLoS Med       Date:  2012-04-10       Impact factor: 11.069

Review 4.  A concern that drug companies cannot ignore.

Authors:  Elizabeth Wager
Journal:  J R Soc Med       Date:  2005-10       Impact factor: 18.000

5.  Restoring invisible and abandoned trials of gabapentin for neuropathic pain: a clinical and methodological investigation.

Authors:  Evan Mayo-Wilson; Xiwei Chen; Riaz Qureshi; Stephanie Dickinson; Lilian Golzarri-Arroyo; Hwanhee Hong; Carsten Görg; Tianjing Li
Journal:  BMJ Open       Date:  2021-06-30       Impact factor: 2.692

6.  Predictability in Contemporary Medicine.

Authors:  Michele M Ciulla
Journal:  Front Med (Lausanne)       Date:  2021-06-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.